O
OrbiMed’s Terns Pharmaceuticals TERN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.2M | Hold |
7,562,971
| – | – | 0.7% | 37 |
|
|
2025
Q1 | $20.9M | Hold |
7,562,971
| – | – | 0.5% | 42 |
|
|
2024
Q4 | $41.9M | Hold |
7,562,971
| – | – | 0.86% | 33 |
|
|
2024
Q3 | $63.1M | Sell |
7,562,971
-56,164
| -0.7% | -$468K | 1.15% | 26 |
|
|
2024
Q2 | $51.9M | Hold |
7,619,135
| – | – | 1.02% | 31 |
|
|
2024
Q1 | $50M | Hold |
7,619,135
| – | – | 0.92% | 39 |
|
|
2023
Q4 | $49.4M | Hold |
7,619,135
| – | – | 0.99% | 37 |
|
|
2023
Q3 | $38.3M | Hold |
7,619,135
| – | – | 0.81% | 46 |
|
|
2023
Q2 | $66.7M | Hold |
7,619,135
| – | – | 1.21% | 31 |
|
|
2023
Q1 | $90.2M | Hold |
7,619,135
| – | – | 1.77% | 16 |
|
|
2022
Q4 | $77.6M | Buy |
7,619,135
+137,931
| +2% | +$1.4M | 1.48% | 22 |
|
|
2022
Q3 | $44.1K | Buy |
7,481,204
+3,690,000
| +97% | +$21.7K | 0.82% | 45 |
|
|
2022
Q2 | $9.4K | Hold |
3,791,204
| – | – | 0.17% | 92 |
|
|
2022
Q1 | $11.3M | Hold |
3,791,204
| – | – | 0.18% | 96 |
|
|
2021
Q4 | $26.8M | Hold |
3,791,204
| – | – | 0.34% | 69 |
|
|
2021
Q3 | $39.5M | Hold |
3,791,204
| – | – | 0.43% | 64 |
|
|
2021
Q2 | $46.5M | Hold |
3,791,204
| – | – | 0.47% | 60 |
|
|
2021
Q1 | $83.4M | Buy |
+3,791,204
| New | +$83.4M | 0.78% | 38 |
|